Potential New Class of Drug for Treating Ulcerative Colitis
San Diego, CA (Scicasts) – According to researchers at the University of California San Diego, School of Medicine, an investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis.
Comments